Today: 7 March 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

AMD stock rises as Intel supply warning jolts chip trade; earnings next in focus

AMD stock rises as Intel supply warning jolts chip trade; earnings next in focus

AMD shares rose 1.9% to $258.50 Friday, extending an eight-session rally after Intel warned of server chip shortages and missed forecasts. Intel stock plunged 16.7% on the news. Investors are positioning ahead of AMD’s Feb. 3 earnings, betting on data-center demand. The broader chip sector fell, with the iShares Semiconductor ETF down 1.3%.
23 January 2026
····
Tesla stock today: TSLA holds near $450 as Musk touts FSD approvals, Autopilot shift

Tesla stock today: TSLA holds near $450 as Musk touts FSD approvals, Autopilot shift

Tesla shares rose 0.2% to $450.30 Friday, extending gains after Elon Musk said Full Self-Driving could win regulatory approval in Europe and China as soon as next month. Tesla dropped “Autopilot” as a standard feature in North America, pushing buyers toward the costlier FSD subscription. California regulators have ordered Tesla to address allegedly deceptive marketing. Tesla registrations in California fell 11.4% in 2025.
23 January 2026
··
Redwire (RDW) stock price jumps again as ‘Golden Dome’ talk keeps buyers in the name

Redwire (RDW) stock price jumps again as ‘Golden Dome’ talk keeps buyers in the name

Redwire shares rose 11.4% to $13.34 by late Friday morning, following a 17.45% surge Thursday amid heavy trading and speculation over U.S. missile-defense plans tied to Greenland. Over 33 million shares traded Thursday, with options activity spiking. The company recently reorganized and launched an at-the-market equity program for up to $250 million. Investors await further details from Washington on the “Golden Dome” project.
23 January 2026
··
ImmunityBio stock price swings as new glioblastoma data hits; IBRX traders eye Jan. 31 update

ImmunityBio stock price swings as new glioblastoma data hits; IBRX traders eye Jan. 31 update

ImmunityBio shares rose 2.7% to $7.54 Friday after updated Phase 2 data showed 19 of 23 glioblastoma patients still alive, with median overall survival unreached. Over 31 million shares traded as investors awaited more trial details at a Jan. 31 summit. The company reported 2025 ANKTIVA revenue of $113 million and year-end cash of $242.8 million. The stock has tripled in three weeks.
23 January 2026
·
Ondas (ONDS) stock slips after SEC resale filing puts more shares in play

Ondas (ONDS) stock slips after SEC resale filing puts more shares in play

Ondas shares fell 2.9% to $12.26 Friday after an SEC filing revealed plans to register 1.62 million shares for resale tied to the Sentry CS acquisition. Around 30 million shares changed hands as the stock swung between $12.04 and $12.85. The new supply may pressure the stock, with investors awaiting the company’s March update on 2025 results.
23 January 2026
Plug Power stock price today: PLUG steadies near $2.60 as share-vote clock ticks and Galp project update lands

Plug Power stock price today: PLUG steadies near $2.60 as share-vote clock ticks and Galp project update lands

Plug Power shares fell 0.2% to $2.59 Friday after a 16.7% surge Thursday. Investors await a Jan. 29 shareholder vote on doubling authorized shares to 3 billion, a move CEO Andy Marsh says is needed to avoid a reverse stock split. Plug and Walmart canceled a 2017 warrant for over 55 million shares, replacing it with a technology licensing deal. Plug completed installation of 100 MW electrolyzers at Galp’s Sines refinery in Portugal.
23 January 2026
···
Enphase Energy (ENPH) stock holds near $40 after Citi and Goldman upgrades — what to watch into earnings

Enphase Energy (ENPH) stock holds near $40 after Citi and Goldman upgrades — what to watch into earnings

Enphase shares edged up less than 0.1% to $40.50 early Friday after jumping 12.54% Thursday on heavy volume. Citi and Goldman Sachs upgraded the stock, citing limited downside and strong Q4 demand tied to tax credit deadlines. Investors are watching early-February results for signs of sustained demand. Enphase remains 43% below its 52-week high.
23 January 2026
···
Robo.ai stock price jumps before the bell on Ghazi Group AI infrastructure deal (AIIO)

Robo.ai stock price jumps before the bell on Ghazi Group AI infrastructure deal (AIIO)

Robo.ai shares jumped about 25% to 33 cents in premarket trading Friday after announcing a three-year reseller deal with The Ghazi Group targeting MENA and Southeast Asia, with projected revenue over $100 million. The stock remains below Nasdaq’s $1 minimum, leaving the company at risk of delisting if it fails to regain compliance by June 8, 2026.
23 January 2026
···
Redwire stock price today: RDW jumps in premarket after 17% surge as “Golden Dome” focus returns

Redwire stock price today: RDW jumps in premarket after 17% surge as “Golden Dome” focus returns

Redwire Corp shares rose 9.9% premarket Friday after surging 17.5% Thursday, trading at $13.16. The rally follows renewed focus on the U.S. “Golden Dome” missile-defense system, with Redwire bidding for project work valued at $542 billion. H.C. Wainwright maintained its $22 price target. The company is restructuring and retiring the Edge Autonomy brand.
23 January 2026
··
Zillow stock jumps nearly 6% as fresh housing forecast lifts focus into earnings

Zillow stock jumps nearly 6% as fresh housing forecast lifts focus into earnings

Zillow Group’s Class C shares rose 5.7% Thursday and traded near $68.59 premarket Friday after the company forecast a 1.2% rise in U.S. home values and a 4.3% increase in existing-home sales for 2026. Benchmark raised its Zillow price target to $110, citing expected housing catalysts. Compass, now merged with Anywhere, is expanding private listings and seeking a legal injunction against Zillow.
23 January 2026
···
Revelation Biosciences (REVB) stock ticks up premarket after FDA lays out Gemini trial path

Revelation Biosciences (REVB) stock ticks up premarket after FDA lays out Gemini trial path

Revelation Biosciences shares rose about 2% premarket after an SEC filing showed FDA agreement on a single adaptive Phase 2/3 trial for its Gemini program in acute kidney injury. The company said strong results from roughly 300 patients could support a U.S. approval filing. Shares last traded near $0.85. Investors remain focused on trial timing and the firm’s $12.7 million cash position.
23 January 2026
··
Lithium price jumps 4% in China, lifting Albemarle and lithium stocks before the Wall Street open

Lithium price jumps 4% in China, lifting Albemarle and lithium stocks before the Wall Street open

Battery-grade lithium carbonate in China jumped 3.95% to 171,000 yuan per metric ton Friday, fueling gains in lithium stocks before the U.S. market opened. Albemarle rose 4.6% in premarket trading, Lithium Americas surged 7.9%, and SQM gained 2.5%. Futures volatility led the Guangzhou Futures Exchange to raise its daily trading limit to 11%. Physical lithium offers ranged from 168,000 to 174,000 yuan per ton.
23 January 2026
···
Oil prices bounce back as Trump’s Iran “armada” talk and Kazakhstan outage lift Brent, WTI

Oil prices bounce back as Trump’s Iran “armada” talk and Kazakhstan outage lift Brent, WTI

Brent crude rose 1.2% to $64.82 a barrel and U.S. WTI climbed 1.3% to $60.11 after President Trump renewed threats against Iran and a Kazakhstan outage tightened supply. Thursday, both benchmarks fell over 1.8% as Trump eased rhetoric and hopes grew for progress on Ukraine. U.S. crude inventories rose 3.6 million barrels last week, according to the EIA. Traders await the Baker Hughes rig count at 1 p.m. ET.
23 January 2026
···
1 … 163 164 165 166 167 … 584
Go toTop